BioPharma Credit Statistics

Total Valuation

BioPharma Credit has a market cap or net worth of GBP 810.15 million. The enterprise value is 780.47 million.

Market Cap	810.15M
Enterprise Value	780.47M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Sep 26, 2024

Share Statistics

BioPharma Credit has 1.19 billion shares outstanding. The number of shares has decreased by -4.55% in one year.

Current Share Class	n/a
Shares Outstanding	1.19B
Shares Change (YoY)	-4.55%
Shares Change (QoQ)	-4.34%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.52%
Float	1.02B

Valuation Ratios

The trailing PE ratio is 9.93.

PE Ratio	9.93
Forward PE	n/a
PS Ratio	7.96
PB Ratio	0.85
P/TBV Ratio	0.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	9.02
EV / Sales	7.16
EV / EBITDA	n/a
EV / EBIT	8.93
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.50

Current Ratio	21.50
Quick Ratio	21.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.56% and return on invested capital (ROIC) is 5.35%.

Return on Equity (ROE)	8.56%
Return on Assets (ROA)	5.33%
Return on Capital (ROIC)	5.35%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.58% in the last 52 weeks. The beta is 0.22, so BioPharma Credit's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-0.58%
50-Day Moving Average	0.87
200-Day Moving Average	0.88
Relative Strength Index (RSI)	38.55
Average Volume (20 Days)	608,705

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPharma Credit had revenue of GBP 107.90 million and earned 86.53 million in profits. Earnings per share was 0.07.

Revenue	107.90M
Gross Profit	107.90M
Operating Income	86.54M
Pretax Income	86.53M
Net Income	86.53M
EBITDA	n/a
EBIT	86.54M
Earnings Per Share (EPS)	0.07

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	29.39M
Total Debt	n/a
Net Cash	29.39M
Net Cash Per Share	0.02
Equity (Book Value)	971.74M
Book Value Per Share	0.80
Working Capital	55.94M

Full Balance Sheet

Cash Flow

Operating Cash Flow	111.11M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 80.20% and 80.20%.

Gross Margin	100.00%
Operating Margin	80.20%
Pretax Margin	80.20%
Profit Margin	80.20%
EBITDA Margin	n/a
EBIT Margin	80.20%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 11.61%.

Dividend Per Share	0.08
Dividend Yield	11.61%
Dividend Growth (YoY)	-0.75%
Years of Dividend Growth	n/a
Payout Ratio	119.60%
Buyback Yield	4.55%
Shareholder Yield	16.16%
Earnings Yield	9.97%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioPharma Credit has an Altman Z-Score of 188.82.

Altman Z-Score	188.82
Piotroski F-Score	n/a